X-linked retinitis pigmentosa is a hereditary retinal degenerative disorder which has been localised to the proximal short arm of the X chromosome. Recent evidence sug gests that the disorder is heterogeneous with two possible loci for the disease muta tion. DNA analysis on the family presented in this paper showed that the mutation mapped to the more telomeric locus (RP3), thus enabling two flanking polymorphic DNA probes (XJ1.1 and M27(3) to be used for the detection of female carriers in the family� In none of the carriers was a tapetal reflex (metallic sheen) observed.
The mechanism of expression of the mutant gene for X-linked recessive retinitis pigmen tosa (XLRP) is unknown. The progressive retinal degeneration commonly manifests with night-blindness in late childhood and severe peripheral and central visual field loss by the third or fourth decade of life. Cataract formation is frequent and some patients may have hearing loss. The diagnosis in an affected male is made by the typical 'bone-spicule' pig mentary changes in the retina arid flattening of the electroretinogram (ERG). The sever- .. ity, relatively early onset and lack of male-to male transmission distinguish XLRP from autosomal dominant and recessive variants. Genetic counselling of females in XLRP fam ilies is difficult without a definitive test for car riers of the gene. Furthermore, there is controversy as to whether the disease gene has more than one locus on the X-chromo some short arm (genetic heterogeneity).
Clinical genetics has been revolutionised in recent years by the identification of DNA markers close to the genes for several com mon genetic disorders e.g. cystic fibrosis. These polymorphic markers are said to be linked to the disease gene and can be used to track the inheritance of the disease gene in families (gene tracking). Thus they provide an accurate means of carrier detection, pre symptomatic and prenatal diagnosis. Several polymorphic DNA probes have now been mapped to the short arm (Xp) of the X-chro mosome (Fig. 1) reported with a centromere marker,2 suggest ing that the RP2 locus was centromeric to LL28. However, the question of genetic hetero geneity was raised by reports of linkage between more distally placed Xp probes (OTC, 754 and XJLl).3,4 In the single large pedigree studied by Nussbaum,3 the carrier females exhibited the tapetal reflex (one form of phenotypic heterogeneity), though only one of the four families studied by Musarella4 had this feature. The data from these OTC17541 XJL 1 linkage studies place the XLRP locus distal to LL28, but proximal to the gene locus for Duchenne muscular dystrophy. Australian studies have suggested mapping of XLRP to an area between the probe loci for 754 and OTe. 5 These alternative loci for the XLRP gene are shown as RP2 (proximal) and RP3 (distal) in Figure I .
Mapping results are not precise as the dis tances between the probe and disease gene loci have 95% confidence limits that extend from 0 to 15 cM for LL28 and from 0.2 to 22 cM for 754. By comparison, the overall length of Xp can be roughly expressed as 90 cM. 6 The genetic distribution of RP in Northern Ireland has been estimated at 31 % autosomal recessive, 19% autosomal dominant, 3% .:,.< y. , :
;!. ':. �:.,» . 
Materials and Methods
The partial pedigree of the· XLRP family is shown in Figure 3 . There are five affected males, two unaffected males and five unaffected sisters in one generation. The mother ( Fig. 3: 2) has peripheral 'bone-spi cule' retinopathy with good vision (suggesting the carrier phenotype) and the affected males had early onset night-blindness (before the age of ten years) and show posterior sub-cap ' sular cataract formation. None of the boys in the third generation are older than eight years and it has not been possible accurately to diagnose carrier status in second generation females on a clinical or ERG basis, despite the eldest being 43 years old. DNA was extracted from venous blood by a method based on that of Jeanpierre,s and the polymorphic DNA fragments resulting from restriction endonuclease digestion were sep arated by overnight electrophoresis in aga rose gels. The DNA was then transferred from gel to nylon membrane by vacuum-blot ting. Seven DNA probelrestriction enzyme combinations were used to identify polymor phisms (Table I) . 50ng probe aliquots were labelled with 32p_dCTP using the random hexanucleotide primer method of Feinberg and Vogelstein9 (Multiprime kit, Amersham Int.). The radio active probe was separated from unincorpor ated nucleotides by passage through a Sephadex G50 column. The appropriate nylon membrane and labelled probe were incubated overnight in a formamide-based hybridisation buffer. Probe that had not hybridised to specific DNA recognition sites was washed off, and the membrane sand wiched between X-ray film (Fuji RX) for three to four days at -70°C.
Results
Polymorphic alleles detected by Xn.1, pERT87.15 and M27� were informative in this family as key carriers were heterozygous. The allele patterns for Xl1.1 and -M27� are shown in Figure 4 . pERT87.15 is similar to Xl1.1 . The distribution of these alleles in the family is shown in Figure 3 .
Of the five affected males, four ( Of the two unaffected males, one (1 2) has XJl.1 allele 2 and M27� allele 4, suggesting that these alleles are inherited with the normal phenotype. His unaffected sibling (6) is unusual in that alleles 1 and 3 have been inherited, a pattern usually associated with the disease phenotype in this family. It is most likely that a 'double' cross-over has occurred in this unaffected male; distally between the disease locus and probe XJl.1 and proximally between the disease locus and M27�. The double cross-over has interrupted the linkage phase between the co-inheritance of alleles 1, Figure 5 .
. The xn.1 and M27� probe results enabled computerised 3-point linkage analysis to be performed. The MLINK section of the pro gram LINKAGE (version 3.5) was used with the recombination rates set to 10% and 20% for the Xn.1 and M27� probes respectively. The approximate likelihood of the double cross-over described above is thus 2% (0.2 x 0.1 = 0.02) and its observation is a rare event. Carrier risk estimates calculated by MLINK are shown in Table II , and can be contrasted with the risk estimations pre viously derived from inspection of the pedi gree only.
Discussion
On the basis of currently available linkage data, neither a proximal (RP2) nor a distal (RP3) site can be excluded as possible XLRP loci. Additional evidence for a distal locus has been deduced from a male patient reported as having Duchenne muscular dystrophy, chronic granulomatous disease, the McLeod . phenotype and XLRP.1O This patient had a chromosomal deletion in the region (pre dicted by linkage analyses) corresponding to the distal RP3 locus. Figure 1 illustrates the putative localisation of the loci in rdation to known DNA markers.
The loci of XJ1.1 and M27� have been accurately mapped and it is known that M27� shows extensive recombination with some XLRP families and little or no recombination with others (Dr I. W. Craig, personal com munication and Mettinger et al.). 11 In this Northern Ireland family, the cross-overs observed suggest that the RP gene is located t>ttween XJ1.1 and M27�. Unlike other reported families with possible distal RP loci,2.12 none of the females in this family exhibited a tapetal reflex. This finding sug gests that the tapetal reflex may not have a strong association with inheritance of RP3.
Currently, OTC and M27� are the closest probes to the RP3 and RP2 loci respectively. M27� is informative in more than 95% of females, as it is multi-allelic, and it should be of great benefit in clarifying the issue of XLRP genetic heterogeneity. The use of M27� in this study enabled 3-point linkage analysis to be performed, so that more accurate genetic counselling can now be offered to this family, with high and low risk potential carriers being clearly distinguished. This had not been pre viously possible.
If XLRP genetic heterogeneity is confirmed (and assuming that there are only two loci), the significance will be as follows:-(1) Linkage studies using current probes and linkage estimates will be applicable only to large individual families.
(2) Carrier risk estimation based on DNA analysis will need prior assignment of fam ilies to the RP2 or RP3 locus. (3) When large families are classified as having either 'proximal' or 'distal' forms of XLRP, it may be possible to find clinical or electrophysiological markers that match this segregation. (4) When clinical assessment is sufficiently refined to segregate 'proximal' and 'distal' families, it will then be possible to use appropriately-linked probes to perform carrier risk estimation in small families.
The relative proportion of families with either putative RP2 or RP3 loci is, as yet, unknown and a review of the current liter ature does not reveal sufficient data on which to base an estimate.
